Literature DB >> 16253893

Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment.

K Martin Hoffmann1, Masayuki Furukawa, Robert T Jensen.   

Abstract

Duodenal neuroendocrine tumors (NETs) comprise 2-3% of all GI endocrine tumors and are increasing in frequency. These include gastrinomas, somatostatinomas, nonfunctional NETs, gangliocytic paragangliomas, and poorly differentiated NE carcinomas. Although, the majority are nonfunctional, these tumors are a frequent cause of Zollinger-Ellison syndrome and can cause other clinical hormonal syndromes (carcinoid, Cushing's, etc.). In this chapter, their epidemiology, clinical aspects, localization, diagnosis and medical treatment are reviewed including the latest advances in each area.

Entities:  

Mesh:

Year:  2005        PMID: 16253893     DOI: 10.1016/j.bpg.2005.05.009

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  53 in total

Review 1.  Surgical treatment of gastrointestinal neuroendocrine tumors.

Authors:  Volker Fendrich; Detlef K Bartsch
Journal:  Langenbecks Arch Surg       Date:  2011-02-01       Impact factor: 3.445

2.  NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

Authors:  Matthew H Kulke; Lowell B Anthony; David L Bushnell; Wouter W de Herder; Stanley J Goldsmith; David S Klimstra; Stephen J Marx; Janice L Pasieka; Rodney F Pommier; James C Yao; Robert T Jensen
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

Review 3.  Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.

Authors:  Robert T Jensen; Marc J Berna; David B Bingham; Jeffrey A Norton
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

Review 4.  Small bowel neuroendocrine tumors: From pathophysiology to clinical approach.

Authors:  Sofia Xavier; Bruno Rosa; José Cotter
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 5.  Neuroendocrine tumors of the gastro-entero-pancreatic system.

Authors:  Sara Massironi; Valentina Sciola; Maddalena Peracchi; Clorinda Ciafardini; Matilde Pia Spampatti; Dario Conte
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 6.  Management of gastric and duodenal neuroendocrine tumors.

Authors:  Yuichi Sato; Satoru Hashimoto; Ken-Ichi Mizuno; Manabu Takeuchi; Shuji Terai
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

Review 7.  Medical treatment of gastrinomas.

Authors:  Christoph J Auernhammer; Burkhard Göke
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 8.  Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-12       Impact factor: 3.043

Review 9.  Duodenal gangliocytic paraganglioma: report of two cases and review of literature.

Authors:  Bo Wang; Yinying Zou; Han Zhang; Liming Xu; Xiaojun Jiang; Ke Sun
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Large gangliocytic paraganglioma of the duodenum: A rare entity.

Authors:  Alejandra Gordillo Hernández; Eduardo Dominguez-Adame Lanuza; Auxiliadora Cano Matias; Rosario Perez Huertas; Katherine Maria Gallardo Rodriguez; Purificacion Gallinato Perez; Fernando Oliva Mompean
Journal:  World J Gastrointest Surg       Date:  2015-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.